about
Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic FibrosisHost-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune ResponseInterleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase PathwayUpdate on chronic viral hepatitisEffect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosisSteatosis affects chronic hepatitis C progression in a genotype specific wayChronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNAFatty liver in chronic hepatitis C infection: unravelling the mechanismsA large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis CA transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humansThe genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular modelLipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis CComparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C.CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.Hepatic lipogranulomas in patients with chronic liver disease: association with hepatitis C and fatty liver disease.Predicting the probable outcome of treatment in HCV patients.Developments in the treatment of chronic hepatitis C.Fibrosis and disease progression in hepatitis C.Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection.Hepatitis C virus biology.Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus.Long term prognosis of fatty liver: risk of chronic liver disease and death.Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.Insulin resistance and steatosis in hepatitis C virus infection.SASLT practice guidelines: management of hepatitis C virus infection.Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients.Hepatitis C and diabetes: the inevitable coincidence?Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.Impact of HCV genetic differences on pathobiology of disease.Lipids and HCV.Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.Lipid profile and hepatic steatosis in hepatitis C infected egyptian survivors of childhood cancer.Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).Viral persistence, liver disease and host response in Hepatitis C-like virus rat model.Laboratory diagnosis of hepatitis C.Permissiveness of human biliary epithelial cells to infection by hepatitis C virus.
P2860
Q26771232-1A8C30C1-2910-41AA-8E7F-E6BC046155F3Q27473258-7C2B77F2-8827-4E2C-8E55-F97CB290B468Q27473476-78F4FE29-48AA-4309-B3C1-67BC6E2B5B81Q27477892-3BF154FC-DB55-43FA-972F-ED1F82F45BA8Q27477968-0869D83E-168D-4527-BDB0-D8320D9A357BQ27477969-2605D942-9CA0-43CC-8222-5274AC80969BQ27478429-2EA182C3-76A8-4300-9338-E2C759C22EFCQ27481041-1662BB04-FAE8-48CE-A41F-455F9867EBE6Q27482028-2446AD29-36D3-4E05-BC92-B9EE203160BFQ27485126-E5AFAB42-9619-4B7B-95BF-F6B2EB0D1642Q27485480-9DA7C0DC-D08E-4D3F-9083-E9059E9D1770Q28081216-B88FAD94-1C2F-4822-9F5A-3F1A1A0DDB87Q30417045-37DA1BE0-A20F-41B0-8956-1FFCF67E31FDQ30463023-94B1950A-3C1D-4369-9316-EC0805B7D615Q32028431-BA1EE77C-2109-4BA8-A368-F2E7B070EDC5Q33867870-06A5AA79-D383-408E-9201-357CBBA43E9EQ34246954-0571D4EF-9A40-442F-87C2-9992F28D3A83Q34409039-7622DBCE-9753-47C8-8396-18DF8D877A96Q34581499-F84C9F39-4F21-4BA8-9C36-007D4CD83143Q34984040-E3B6518A-7165-4062-88BF-A6D0A9497955Q35045338-C8D3C807-CC10-4BE5-964F-0242C0474CEBQ35091465-6E4088CF-D3FA-4762-8A1D-CC9FC1E7C60CQ35143996-1567A856-D91F-4CE0-B681-0F267254DDC2Q35596463-5A4F0806-7694-4C4C-AA76-676170076B5FQ35598407-75702439-0D7F-4B32-AF94-A0DF39EFE65DQ36160709-B614AABA-DD6E-4F47-9C6C-8DFC38B452FAQ37019765-2727EAA0-9F80-4F72-BED7-144B6041FD71Q37126762-488822D8-15F0-4909-8F1E-65E092C03DEEQ37277880-8141292F-DF66-455E-887C-8F2BDA65348CQ37432092-DEDA22AF-B6F2-4DF1-8C77-760824C3028DQ37769184-29EF5ADE-A36D-4CAC-8322-0822473234C4Q37929753-2CE01C61-4B4A-4820-A6CA-5995E6BCE3B6Q38056643-420050F6-CF44-43D4-9E5D-BB548B8DD466Q38071935-E35F799A-A3D4-4A15-80FC-B3A7C8B0920AQ38866756-827DF48F-5A80-423A-BB2D-C28D46CB2331Q39410431-9298EDEF-E504-4E51-A071-8C3944E894EDQ39631188-FEA897B8-C986-475D-A36E-677DBD6AD879Q40062848-C2335FD7-37EB-4C88-ACE8-90C913A7FD93Q41351271-E1B913E2-3961-42C9-8904-777F77DC2327Q42993187-06880441-4E8F-490A-A9C3-7842EDD87C24
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Histopathology of hepatitis C virus infection.
@en
type
label
Histopathology of hepatitis C virus infection.
@en
prefLabel
Histopathology of hepatitis C virus infection.
@en
P356
P1476
Histopathology of hepatitis C virus infection.
@en
P2093
P356
10.1055/S-2007-1007264
P577
1995-02-01T00:00:00Z